| Completed | A Phase III Study for 601 Versus Ranibizumab in Patients With Vision Loss NCT05520177 | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | Phase 3 |
| Active Not Recruiting | A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products NCT05476926 | Hoffmann-La Roche | — |
| Terminated | EffiCacy, Safety and ToLErability of a Novel Ocular ANtiseptic for Ocular Use (CLEAN) NCT05127525 | iRenix Medical, Inc. | Phase 3 |
| Unknown | Phase I Study of Episcleral Celecoxib for Treatment of Macular Edema and Inflammatory Disorders of the Posteri NCT04120636 | Targeted Therapy Technologies, LLC | Phase 1 |
| Completed | A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Branc NCT04740905 | Hoffmann-La Roche | Phase 3 |
| Completed | 601 Versus Ranibizumab in Patients With Branch Retinal Vein Occlusion (BRVO) NCT04667897 | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | Phase 2 |
| Completed | Assessment Of Peri-papillary Retinal Nerve Fiber Layer Thickness In Patients With Unilateral Branch Retinal Ve NCT06146309 | Al-Azhar University | N/A |
| Unknown | Branch Retinal Vein Occlusion (BRVO) Treatment With Bevacizumab and Dexamethasone or Bevacizumab Only. NCT04601688 | He Eye Hospital | N/A |
| Unknown | Episcleral Dexamethasone for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole NCT04120311 | Targeted Therapy Technologies, LLC | Phase 1 |
| Terminated | Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to NCT03802630 | Novartis Pharmaceuticals | Phase 3 |
| Unknown | Anti-VEGF Instead of Intraoperative Fan-shaped Photocoagulation in BRVO Combined With Vitreous Hemorrhage NCT03637283 | Wenzhou Medical University | N/A |
| Completed | Navigated Laser In Branch Retinal Vein Occlusion Study NCT03651011 | Odense University Hospital | N/A |
| Completed | Combination of Intravitreal Ranibizumab With or Without Macular Laser Photocoagulation for ME Secondary to BRV NCT03054766 | Beijing Hospital | N/A |
| Completed | Conbercept Ophthalmic Injection for Patients With Macular Edema Caused by Branch Retinal Vein Occlusion NCT03108352 | Chengdu Kanghong Biotech Co., Ltd. | Phase 3 |
| Completed | Peripheral and Macular Retinal Vascular Perfusion and Leakage in DME and RVO NCT02503540 | Justis Ehlers | Phase 4 |
| Unknown | Assessment of Retinal Vessel Diameters and Red Blood Velocities in Patients With BRVO and Healthy Subjects NCT01746615 | Medical University of Vienna | N/A |
| Unknown | Retinal Sensitivity in BRVO After Anti-VEGF Therapy NCT02527733 | Fukushima Medical University | Phase 4 |
| Completed | Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study NCT02390245 | Wills Eye | N/A |
| Completed | Evaluation of the Usefulness of a PRN Regimen Using Ranibizumab for Macular Edema Due to Branch Retinal Vein O NCT02478515 | Nagoya City University | Phase 4 |
| Unknown | Development of Intravitreal Ranibizumab by Determining the Pathogenesis of Macular Edema With Retinal Vein Occ NCT02169648 | Tokyo Medical University | N/A |
| Completed | Proof of Concept Study of Re-treatment in BRVO With Ranibizumab Guided by OCT NCT01968239 | University of Leipzig | Phase 2 |
| Unknown | Non-damaging Retinal Laser Therapy With PASCAL Laser for Macular Diseases NCT01975103 | Federal University of Rio Grande do Sul | Phase 2 |
| Terminated | Ranibizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion in Patients With Fair Vision NCT01795209 | Seoul National University Bundang Hospital | Phase 4 |
| Completed | Long-term Treatment Effect of Intravitreal Ant-VEGF in Branch Retinal Vein Occlusion NCT02033031 | Medical University of Vienna | Phase 3 |
| Completed | Efficacy and Safety of Ranibizumab With or Without Laser in Comparison to Laser in Branch Retinal Vein Occlusi NCT01599650 | Novartis Pharmaceuticals | Phase 3 |
| Completed | Retinal Vessel Diameter in Branch Retinal Vein Occlusion NCT02215109 | Kyungpook National University Hospital | — |
| Completed | Study to Assess the Clinical Efficacy and Safety of Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321) NCT01521559 | Regeneron Pharmaceuticals | Phase 3 |
| Unknown | Retinal Oxygen Saturation, Blood Flow, Vascular Function and High Resolution Morphometric Imaging in the Livin NCT01348633 | University of Toronto | — |
| Completed | Combined Therapy of Posterior Subtenon Triamcinolone Acetonide and Intravitreal Bevacizumab for Macular Edema NCT01614509 | Yeungnam University College of Medicine | N/A |
| Completed | Intravitreal Ranibizumab 0.5MG, or 1.0mg for RVO With Macular Edema Previously Receiving Bevacizumab NCT01471691 | Hanscom, Thomas, M.D. | Phase 1 / Phase 2 |
| Unknown | A Research Study to Evaluate the Effects of Repeated Intravitreal Injections on Bacteria Around the Eye NCT01531842 | Mid Atlantic Retina | N/A |
| Completed | Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patien NCT01396057 | Novartis Pharmaceuticals | Phase 3 |
| Completed | REtinal Vein OccLUsion Treatment With Scatter Laser Guided by UWFA in combiNAtion With Ranibizumab Study NCT01247220 | Retina Associates of Florida, P.A. | Phase 2 |
| Unknown | Intravitreal Bevasizumab Versus Intravitreal Triamcinolone in Branch Retinal Vein Occlusion NCT01044329 | Shahid Beheshti University of Medical Sciences | Phase 2 |
| Unknown | Comparison of Intravitreal Ranibizumab and Macular Laser Photocoagulation for ME Following Branch Retinal Vein NCT01189526 | Seoul Retina Investigator Group | Phase 3 |
| Unknown | Atorvastatin for the Treatment of Retinal Vein Occlusion NCT00517257 | University of Toronto | Phase 3 |
| Terminated | Retrospective Study of the Effectiveness and Safety of Niacin and Steroid Eye Drops for Retinal Vein Occlusion NCT00500045 | Palo Alto Medical Foundation | Phase 2 / Phase 3 |
| Completed | A Pilot Study of Functional Optical Coherence Tomography for Ocular Imaging NCT00556114 | University of California, Irvine | — |
| Terminated | Combined Vitrectomy and Triamcinolone in Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO) NCT00642226 | Helse Stavanger HF | Phase 3 |
| Completed | Sheathotomy vs. Intravitreal Triamcinolone for Branch Retinal Vein Occlusion NCT00612261 | Yonsei University | N/A |
| Completed | Evaluation of Macugen Treatment of Macular Edema Due to Branch Retinal Vein Occlusion NCT00406107 | Palmetto Retina Center, LLC | Phase 4 |
| Completed | Intravitreal Triamcinolone for Acute Branch Retinal Vein Occlusion NCT00370266 | Shahid Beheshti University of Medical Sciences | Phase 2 |
| Completed | A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Branch Retinal Vein Occ NCT00308477 | Sanwa Kagaku Kenkyusho Co., Ltd. | Phase 1 / Phase 2 |